Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures-Reference-Cited by-同舟云学术

Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures

Published:2023-11-08 Issue:12 Volume:12 Page:642-645
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Abu-Raya Bahaa¹²,Reicherz Frederic¹²³,Michalski Christina¹²,Viñeta Paramo Marina¹²,Majdoubi Abdelilah¹²,Golding Liam¹²,Granoski Madison⁴^ORCID,Stojic Aleksandra⁴,Marchant David J⁴,Lavoie Pascal M¹²

Affiliation:

1. British Columbia Children’s Hospital Research Institute , Vancouver, British Columbia , Canada

2. Department of Pediatrics, Faculty of Medicine, University of British Columbia , Vancouver, British Columbia , Canada

3. Department of Pediatrics, Children’s Hospital Datteln, University of Witten/Herdecke , Datteln , Germany

4. Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta , Edmonton , Canada

Abstract

Abstract Studies have linked respiratory syncytial virus (RSV) antibody-mediated phagocytosis and complement deposition to severe RSV infection in humans. This study shows waning of these antibody functions in women of childbearing age in 2020-2021 during the implementation of COVID-19 mitigation measures, in absence of RSV circulation. These functions could be explored as correlates of protection against severe RSV disease.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

https://academic.oup.com/jpids/advance-article-pdf/doi/10.1093/jpids/piad099/53097769/piad099.pdf

Reference18 articles.

1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Collaborators GLRI;Lancet Infect Dis,2018

2. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease;Simoes;J Pediatr,2003

3. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33–35 weeks in Spain;Figueras-Aloy;Pediatr Infect Dis J,2004

4. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

5. Human T cells efficiently control RSV infection;De;JCI Insight,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations of pathogen transmission patterns and attenuated immune stimulation might be the cause of increased adult respiratory infections cases in 2023, results from a multi-center study in mainland China;Heliyon;2024-06